Stock STIM NEURONETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Neuronetics, Inc.

Equities

STIM

US64131A1051

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/04/2024 am IST 		5-day change 1st Jan Change
3.49 USD -0.85% Intraday chart for Neuronetics, Inc. -8.16% +20.34%
10/04 Neuronetics, Inc. Announces the Publication of Significant Clinical Findings in Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation CI
28/03 Neuronetics, Inc. Announces John K. Bakewell, Joseph H. Capper and Dr. Wilfred E. Jaeger Not Stand for Reelection to the Board CI

Evolution of the average Target Price on Neuronetics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

3c3b2903f1fdc17353.8ampggUwij0j1WF6VpSZbUTDRAzL_E2l_GWwCgvgCXM.mM6d0XR5xHlLsw8wH-HNIx2sCkO9lgTOyy7KSEK1YTaS4PnQSHzTcRq-Fg~c064214033a6822961048d73b7963616

Analyst Recommendations on Neuronetics, Inc.

Canaccord Genuity Adjusts Price Target on Neuronetics to $7 From $9, Maintains Buy Rating MT
Piper Sandler Adjusts Neuronetics' Price Target to $9 From $10, Reiterates Overweight Rating MT
NEURONETICS : JMP Securities Adjusts Price Target on Neuronetics to $12 From $18, Maintains Market Outperform Rating MT
NEURONETICS : William Blair Downgrades Neuronetics to Market Perform From Outperform MT
NEURONETICS : BTIG Downgrades Neuronetics to Neutral from Buy MT
NEURONETICS : William Blair Upgrades Neuronetics to Outperform From Market Perform MT
NEURONETICS : Piper Sandler Adjusts Neuronetics' Price Target to $27 from $20, Keeps Overweight Rating MT
NEURONETICS : BTIG Research Adjusts Neuronetics PT to $21 From $14, Maintains Buy Rating MT
NEURONETICS : BTIG Research Adjusts Neuronetics PT to $14 From $10, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
3.49 USD
Average target price
7 USD
Spread / Average Target
+100.57%
High Price Target
8 USD
Spread / Highest target
+129.23%
Low Price Target
6 USD
Spread / Lowest Target
+71.92%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Neuronetics, Inc.

Canaccord Genuity
Piper Sandler
JMP Securities
BTIG
William Blair & Co.

Ratings for Neuronetics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. STIM Stock
  4. Consensus Neuronetics, Inc.